Mitchell Shiffman

739 total citations
10 papers, 466 citations indexed

About

Mitchell Shiffman is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mitchell Shiffman has authored 10 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Mitchell Shiffman's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Mitchell Shiffman is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Mitchell Shiffman collaborates with scholars based in United States, United Kingdom and France. Mitchell Shiffman's co-authors include Paul J. Pockros, Robert Reindollar, Jean DePamphilis, Gregory T. Everson, Coleman I. Smith, Amy Lin, K. Rajender Reddy, Preston P. Purdum, Michael Fried and William M. Lee and has published in prestigious journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Mitchell Shiffman

10 papers receiving 440 citations

Peers

Mitchell Shiffman

HEPAT

EPIDE

IMMUN

RHEUM

Ricardo Moreno-Otero Spain

Tadashi Takeda Japan

C. Pintus Italy

Alaa Ismail Egypt

Seitetsu Yoon Japan

Mika Miura Japan

Tsuneaki Tagaya Japan

Chia-Wei Hsieh Taiwan

Hossein Sendi United States

J.-P. Bronowicki France

Ricardo Moreno-Otero Spain

Mitchell Shiffman

262 ×0.8

HEPAT

211 ×0.7

EPIDE

52 ×0.7

IMMUN

55 ×1.0

RHEUM

32 ×0.7

Citations per year, relative to Mitchell Shiffman Mitchell Shiffman (= 1×) peers Ricardo Moreno-Otero

Countries citing papers authored by Mitchell Shiffman

Since Specialization

Citations

This map shows the geographic impact of Mitchell Shiffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Shiffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Shiffman more than expected).

Fields of papers citing papers by Mitchell Shiffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Shiffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Shiffman. The network helps show where Mitchell Shiffman may publish in the future.

Co-authorship network of co-authors of Mitchell Shiffman

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Shiffman. A scholar is included among the top collaborators of Mitchell Shiffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Shiffman. Mitchell Shiffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2023). Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 15(10). 2026–2026. 4 indexed citations

Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2019). THU-138-High efficacy and improvement in CPT class with sofosbuvir/velpatasvir plus ribavirin for 12 weeks in patients with CPT C decompensated cirrhosis. Journal of Hepatology. 70(1). e221–e222. 2 indexed citations

García–Tsao, Guadalupe, Jaime Bosch, Zeid Kayali, et al.. (2019). LBO-01-Multicenter, double-blind, placebo-controlled, randomized trial of emricasan in subjects with NASH cirrhosis and severe portal hypertension. Journal of Hepatology. 70(1). e127–e127. 7 indexed citations

Shiffman, Mitchell, et al.. (2014). Treatment of Chronic HCV With Sofosbuvir (SOF) and Simeprevir (SMV) in Patients With Cirrhosis and Contraindications to Peginterferon (PEGINF) and Ribavirin (RBV). The American Journal of Gastroenterology. 109. S154–S155. 1 indexed citations

Ahmad, Tariq, Philip D. Yin, Jeffrey E. Saffitz, et al.. (2014). Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. Hepatology. 62(2). 409–416. 56 indexed citations

Smith, Jenny O., Richard K. Sterling, A. Scott Mills, et al.. (2008). Herpes Simplex Virus Colitis in a Patient with Crohnʼs Disease and Hepatitis B and D Cirrhosis. The American Journal of Gastroenterology. 103. S336–S336. 7 indexed citations

McHutchison, John G., Bruce R. Bacon, Stuart C. Gordon, et al.. (2007). Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus. Hepatology. 46(5). 1341–1349. 94 indexed citations

Shiffman, Mitchell. (2004). Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.. Cleveland Clinic Journal of Medicine. 71(Suppl_3). S13–S13. 6 indexed citations

Reddy, K. Rajender, Teresa L. Wright, Paul J. Pockros, et al.. (2001). Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C. Hepatology. 33(2). 433–438. 284 indexed citations

10.

Shiffman, Mitchell, et al.. (1996). Isolated Gastric Varices Associated with Spontaneous Splenorenal Shunt. Digestive Diseases. 14(3). 209–210. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact